ifosfamide has been researched along with Melanoma in 14 studies
Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A phase II study with cisplatin plus 24-hour infusion of ifosfamide (with mesna uroprotection) was performed in patients with metastatic malignant melanoma." | 7.68 | Phase II study of cisplatin plus 24-hour infusion of ifosfamide in advanced malignant melanoma. ( Planting, AS; Stoter, G; van der Gaast, A; Verweij, J, 1990) |
| "Thirty-seven patients with widely metastatic malignant melanoma were treated with one of three chemotherapy regimens, incorporating high-dose dacarbazine (DTIC)." | 7.67 | High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma. ( Carr, T; Chadwick, G; Craig, P; Jones, R; Lind, M; Morgenstern, G; Thatcher, D, 1989) |
| "Ifosfamide was tested in a phase II study in 12 evaluable patients with advanced malignant melanoma." | 7.67 | Phase II study with ifosfamide in advanced malignant melanoma. ( Bajetta, E; Bonfante, V; Ferrari, L; Negretti, E, 1988) |
| "Twenty-five patients with measurable lesions of advanced malignant melanoma received a combined chemotherapy containing cis-dichlordiammineplatinum (II) (cisplatin) 30 mg daily at days 1, 3, 5, 7, 9, and ifosfamide 45 mg/kg at days 2, 4, 6, 8, and 10." | 7.66 | Combination chemotherapy with ifosfamide and cis-dichlorodiammineplatinum (II) in advanced malignant melanoma. ( Becher, R; Schmidt, CG; Seeber, S, 1980) |
| " Both have a dose-response relationship." | 6.68 | Phase II study of a closely spaced ifosfamide--cisplatin schedule with the addition of G-CSF in advanced non-small-cell lung cancer and malignant melanoma. ( de Wit, R; Planting, AS; Stoter, G; van der Burg, ME; Verweij, J, 1996) |
| "Vaginal melanoma is a very rare but highly malignant gynecological disease, usually diagnosed in postmenopausal woman." | 6.43 | Primary malignant vaginal melanoma treated with adriamycin and ifosfamide: a case report and literature review. ( Garbi, A; Lissoni, AA; Mangioni, C; Perego, P; Signorelli, M, 2005) |
| "Thirty-seven patients with widely metastatic malignant melanoma were treated with one of three chemotherapy regimens, incorporating high-dose dacarbazine (DTIC)." | 3.67 | High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma. ( Carr, T; Chadwick, G; Craig, P; Jones, R; Lind, M; Morgenstern, G; Thatcher, D, 1989) |
| "Ifosfamide was tested in a phase II study in 12 evaluable patients with advanced malignant melanoma." | 3.67 | Phase II study with ifosfamide in advanced malignant melanoma. ( Bajetta, E; Bonfante, V; Ferrari, L; Negretti, E, 1988) |
| "Twenty-five patients with measurable lesions of advanced malignant melanoma received a combined chemotherapy containing cis-dichlordiammineplatinum (II) (cisplatin) 30 mg daily at days 1, 3, 5, 7, 9, and ifosfamide 45 mg/kg at days 2, 4, 6, 8, and 10." | 3.66 | Combination chemotherapy with ifosfamide and cis-dichlorodiammineplatinum (II) in advanced malignant melanoma. ( Becher, R; Schmidt, CG; Seeber, S, 1980) |
| " Both have a dose-response relationship." | 2.68 | Phase II study of a closely spaced ifosfamide--cisplatin schedule with the addition of G-CSF in advanced non-small-cell lung cancer and malignant melanoma. ( de Wit, R; Planting, AS; Stoter, G; van der Burg, ME; Verweij, J, 1996) |
| "Vaginal melanoma is a very rare but highly malignant gynecological disease, usually diagnosed in postmenopausal woman." | 2.43 | Primary malignant vaginal melanoma treated with adriamycin and ifosfamide: a case report and literature review. ( Garbi, A; Lissoni, AA; Mangioni, C; Perego, P; Signorelli, M, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (71.43) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Signorelli, M | 1 |
| Lissoni, AA | 1 |
| Garbi, A | 1 |
| Perego, P | 1 |
| Mangioni, C | 1 |
| Focan, C | 1 |
| Salamon, E | 1 |
| Le Hung, S | 1 |
| Frère, MH | 1 |
| Mbuyamba, P | 1 |
| Claessens, JJ | 1 |
| Osieka, R | 1 |
| Costanzi, JJ | 1 |
| Stephens, R | 1 |
| O'Bryan, R | 1 |
| Franks, J | 1 |
| Becher, R | 2 |
| Seeber, S | 1 |
| Schmidt, CG | 2 |
| Balda, BR | 1 |
| Jehn, U | 1 |
| Klövekorn, W | 1 |
| Wohlrab, A | 1 |
| Berdel, WE | 1 |
| Fink, U | 1 |
| Emmerich, B | 1 |
| Maubach, PA | 1 |
| Busch, U | 1 |
| Remy, W | 1 |
| Rastetter, J | 1 |
| Planting, AS | 2 |
| de Wit, R | 1 |
| van der Burg, ME | 1 |
| Stoter, G | 2 |
| Verweij, J | 2 |
| Latz, D | 1 |
| Schulze, T | 1 |
| Manegold, C | 1 |
| Schraube, P | 1 |
| Flentje, M | 1 |
| Weber, KJ | 1 |
| van der Gaast, A | 1 |
| Thatcher, D | 1 |
| Lind, M | 1 |
| Morgenstern, G | 1 |
| Carr, T | 1 |
| Chadwick, G | 1 |
| Jones, R | 1 |
| Craig, P | 1 |
| Tsukagoshi, S | 1 |
| Negretti, E | 1 |
| Ferrari, L | 1 |
| Bonfante, V | 1 |
| Bajetta, E | 1 |
1 review available for ifosfamide and Melanoma
| Article | Year |
|---|---|
Primary malignant vaginal melanoma treated with adriamycin and ifosfamide: a case report and literature review.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Humans; Ifosfamide; Melan | 2005 |
1 trial available for ifosfamide and Melanoma
| Article | Year |
|---|---|
Phase II study of a closely spaced ifosfamide--cisplatin schedule with the addition of G-CSF in advanced non-small-cell lung cancer and malignant melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1996 |
12 other studies available for ifosfamide and Melanoma
| Article | Year |
|---|---|
[Efficacy of sequential chemotherapy including vincristine, cisplatin and ifosfamide in the treatment of stage IV head and neck carcinomas and melanomas with visceral involvement. Preliminary results].
Topics: Abdominal Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamou | 1984 |
Studies on drug resistance in a human melanoma xenograft system.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Disease Models, Ani | 1984 |
Ifosfamide in the management of malignant melanoma: a Southwest Oncology Group Phase II Study.
Topics: Bone Marrow; Cyclophosphamide; Drug Administration Schedule; Drug Evaluation; Humans; Ifosfamide; Me | 1982 |
Combination chemotherapy with ifosfamide and cis-dichlorodiammineplatinum (II) in advanced malignant melanoma.
Topics: Adult; Aged; Cisplatin; Cyclophosphamide; Dacarbazine; Drug Synergism; Drug Therapy, Combination; Fe | 1980 |
[Combination chemotherapy with cis-dichloro-diammineplatinum (II) and ifosfamide in malignant melanomas (author's transl)].
Topics: Adult; Cisplatin; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Ifosfamide; Male; Mel | 1981 |
[Chemotherapy of malignant melanoma with cis-diaminodichloroplatinum and ifosfamid (author's transl)].
Topics: Adult; Cisplatin; Cyclophosphamide; Humans; Ifosfamide; Male; Melanoma; Middle Aged; Skin Neoplasms | 1982 |
Combined effects of ionizing radiation and 4-hydroperoxyfosfamide in vitro.
Topics: Animals; Carcinoma, Squamous Cell; Cell Cycle; Cell Survival; Colonic Neoplasms; Combined Modality T | 1998 |
[Combined chemotherapy of metastasing melanoblastoma using ifosfamide and cis-platinum (II)-diamminodichloride (author's transl)].
Topics: Adult; Aged; Cisplatin; Cyclophosphamide; Female; Humans; Ifosfamide; Male; Melanoma; Middle Aged; N | 1979 |
Phase II study of cisplatin plus 24-hour infusion of ifosfamide in advanced malignant melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Female; Hum | 1990 |
High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma.
Topics: Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Ma | 1989 |
[Ifomide].
Topics: Animals; Bone Neoplasms; Carcinoma, Small Cell; Female; Humans; Ifosfamide; Leukemia, Experimental; | 1987 |
Phase II study with ifosfamide in advanced malignant melanoma.
Topics: Adult; Drug Evaluation; Humans; Ifosfamide; Melanoma; Middle Aged; Neoplasm Metastasis | 1988 |